ADVFN - ニュース

S&P 500

5,464.62

-0.16%

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/22	05 : 05	Edgar (US Regulatory)	Form F-6 - Registration of American Depository Receipt shares, not immediately effective	NYSE:ABB	ABB Ltd
2024/06/22	05 : 05	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	USOTC:SMTKD	SmartKem Inc (QB)
2024/06/22	05 : 05	GlobeNewswire Inc.	Blackwells Releases Letter to Fellow Shareholders Highlighting Ongoing Corporate Piracy Being Carried Out by Braemar Chairman Monty Bennett and His Cronies	NYSE:BHR	Braemar Hotels and Resorts Inc
2024/06/22	05 : 05	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	USOTC:SMTKD	SmartKem Inc (QB)
2024/06/22	05 : 05	GlobeNewswire Inc.	Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 20 June 2024	EU:IVA	Inventiva
2024/06/22	05 : 05	PR Newswire (Canada)	Otipemisiwak Métis Government Celebrates the Opening and Ribbon Cutting of Salay Prayzaan Solar Farm
2024/06/22	05 : 05	GlobeNewswire Inc.	DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS AUTORISE PAR L'ASSEMBLEE GENERALE ORDINAIRE DU 20 JUIN 2024	EU:IVA	Inventiva
2024/06/22	05 : 05	Business Wire	WPP, Ogilvy and The Coca-Cola Company win at Cannes Lions 2024	NYSE:WPP	WPP PLC
2024/06/22	05 : 05	GlobeNewswire Inc.	Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 20 June 2024	LSE:0RNK	Inventiva Sa
2024/06/22	05 : 05	GlobeNewswire Inc.	Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 20 June 2024	TG:6IV	Inventiva
2024/06/22	05 : 05	GlobeNewswire Inc.	DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS AUTORISE PAR L'ASSEMBLEE GENERALE ORDINAIRE DU 20 JUIN 2024	TG:6IV	Inventiva
2024/06/22	05 : 05	PR Newswire (US)	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:TMDX	TransMedics Group Inc
2024/06/22	05 : 05	GlobeNewswire Inc.	Alpine Income Property Trust Announces Year-To-Date 2024 Transaction Activity	NYSE:PINE	Alpine Income Property Trust Inc
2024/06/22	05 : 05	GlobeNewswire Inc.	Singular Genomics Announces 1-for-30 Reverse Stock Split	NASDAQ:OMIC	Singular Genomics Systems Inc
2024/06/22	05 : 05	PR Newswire (US)	Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:RNA	Avidity Biosciences Inc
2024/06/22	05 : 05	GlobeNewswire Inc.	DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS AUTORISE PAR L'ASSEMBLEE GENERALE ORDINAIRE DU 20 JUIN 2024	LSE:0RNK	Inventiva Sa
2024/06/22	05 : 05	PR Newswire (US)	Marvell Technology, Inc. Declares Quarterly Dividend Payment	NASDAQ:MRVL	Marvell Technology Inc
2024/06/22	05 : 05	GlobeNewswire Inc.	Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 20 June 2024	EU:IVA	Inventiva
2024/06/22	05 : 05	Business Wire	Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook	AMEX:SENS	Senseonics Holdings Inc
2024/06/22	05 : 05	Business Wire	Volato Announces Receipt of Continued Listing Standards Notice from NYSE American	AMEX:SOAR	Volato Group Inc
2024/06/22	05 : 04	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	USOTC:PLNHF	Planet 13 Holdings Inc (QX)
2024/06/22	05 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SQL	SeqLL Inc
2024/06/22	05 : 04	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:GS-J	Goldman Sachs Group Inc
2024/06/22	05 : 04	GlobeNewswire Inc.	On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development	TSXV:NRX	Nurexone Biologic Inc
2024/06/22	05 : 04	GlobeNewswire Inc.	On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development	TG:J90	NurExone Biologic Inc
2024/06/22	05 : 04	GlobeNewswire Inc.	On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development	J90
2024/06/22	05 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ENOB	Enochian Biosciences Inc
2024/06/22	05 : 01	GlobeNewswire Inc.	Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	NASDAQ:FBIO	Fortress Biotech Inc
2024/06/22	05 : 01	GlobeNewswire Inc.	Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	NASDAQ:MBIO	Mustang Bio Inc
2024/06/22	05 : 01	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:AMJ	JP Morgan Alerian MLP